Phenylalanine hydroxylase (PAH)

Assets acting on this target.

Class
Synthetic cofactor (BH4) replacement
Notes
mechanism wave 2026-08-24 (PubMed co-occurrence, 217 article(s)); source: https://pubmed.ncbi.nlm.nih.gov/42616575/

By indication

Related mechanisms

Phenylalanine hydroxylase (PAH) drugs compared

2 drugs, stage by indication
2 drugs acting on Phenylalanine hydroxylase (PAH): developer, modality, furthest stage and stage in each indication. Furthest stage first.
DrugDeveloperModalityFurthest stageStage by indication
Sapropterin Dihydrochloride (Kuvan)KuvanBioMarin Pharmaceuticalsmall moleculeApprovedApproved in Phenylketonuria
SepiapterinPTC Therapeuticssmall moleculeApprovedApproved in Phenylketonuria

← all mechanisms